STOCK TITAN

Houlihan Lokey, Inc. 8-K Filings

HLI NYSE

Every 8-K that Houlihan Lokey, Inc. (HLI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow HLI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLI filings page.

Rhea-AI Summary

Houlihan Lokey, Inc. (HLI) reported outcomes from its September 16, 2026 annual meeting, including stockholder approval of the Second Amended and Restated 2016 Incentive Award Plan, which was previously adopted by the board and became effective as of that meeting. The plan governs equity and incentive compensation for eligible participants.

The board elected Thomas Reichert as an independent Class I director, effective October 1, 2026, with a term running to the 2028 annual meeting. He will join the Audit and Nominating and Corporate Governance Committees and received a $120,000 restricted stock award under the new plan, vesting over three years, with accelerated vesting upon death or disability.

The company announced a leadership transition in its top legal role: Christopher M. Crain retired as General Counsel and became Corporate Senior Advisor, while the board appointed Prabha Sipi Bhandari as Chief Legal Officer and Secretary, an executive officer role. Stockholders also re-elected three Class II directors and approved say-on-pay and auditor ratification, each by substantial majorities.

Rhea-AI Summary

Houlihan Lokey, Inc. (HLI) announced a planned change to its board of directors. On September 3, 2026, director Gillian B. Zucker informed the board that she does not intend to stand for reelection when her term expires at the company’s 2026 Annual Meeting of Stockholders. The company states that Ms. Zucker’s decision is not the result of any disagreement with Houlihan Lokey regarding its operations, policies, or practices.

Rhea-AI Summary

Houlihan Lokey, Inc. filed a prospectus supplement covering the potential resale from time to time of up to 255,422 shares of Class A common stock issuable upon conversion of an equal number of Class B shares held by former Waller Helms Advisors LLC members, and up to 109,656 shares of Class A common stock issuable upon conversion of Class B shares held by former members of 7 Mile Advisors, LLC. These shares arise from consideration and related instruments issued in the December 2024 Waller Helms acquisition and the December 2023 7MA acquisition, including performance-based issuances and convertible note conversions. All securities were previously registered for resale under an earlier Form S-3 that has been replaced by a new Form S-3 filed on August 10, 2026.

Rhea-AI Summary

Houlihan Lokey reported first quarter fiscal 2027 results for the quarter ended June 30, 2026, with revenue of $511 million, down from $605 million a year earlier. Net income attributable to the company was $78 million, or $1.15 diluted EPS, versus $98 million and $1.42. Adjusted net income was $91 million and adjusted diluted EPS $1.35, compared with $148 million and $2.14.

Corporate Finance revenue fell to $303 million, Financial Restructuring to $119 million, while Financial and Valuation Advisory grew to $89 million. Management attributed weaker results mainly to headwinds in Corporate Finance from instability in the Middle East and disruptions in the technology sector and stated it believes these are temporary.

Compensation expense declined to $328 million, a 64.3% compensation ratio, and non-compensation expense to $105 million, while the effective tax rate rose to 9.8%. The board declared a $0.70 quarterly dividend for the second quarter of fiscal 2027, the company repurchased 348 thousand shares, and held $797 million in cash and investment securities as of June 30, 2026.

Rhea-AI Summary

Houlihan Lokey reported record fiscal 2026 results, with revenues of $2.62 billion versus $2.39 billion a year earlier. Full-year diluted EPS rose to $6.22 from $5.82, and adjusted diluted EPS increased to $7.56 from $6.29, reflecting higher Corporate Finance and valuation activity.

Fourth-quarter results were softer, as revenues declined to $636 million from $666 million and diluted EPS fell to $1.47 from $1.76, mainly due to lower Financial Restructuring revenue. The Board raised the quarterly dividend by 16.7% to $0.70 per share and the company ended March 31, 2026 with $1.36 billion of unrestricted cash, cash equivalents, and investment securities.

Rhea-AI Summary

Houlihan Lokey, Inc. filed a prospectus supplement covering the possible resale of up to 4,009 shares of its Class A common stock issuable upon conversion of an equal number of Class B shares held by former members of Waller Helms Advisors LLC.

The supplement also covers the possible resale of some or all of 28,412 Class A shares issuable upon conversion of an equal number of Class B shares held by the former members of 7 Mile Advisors, LLC, issued upon attainment of post-closing performance targets and conversion of related convertible notes. The company also filed a legal opinion from Latham & Watkins LLP as an exhibit.

Rhea-AI Summary

Houlihan Lokey, Inc. reported that director Robert A. Schriesheim has informed the company that he does not intend to stand for reelection to the board when his current term ends at the company’s 2027 Annual Meeting of Shareholders.

Schriesheim has served as a director of Houlihan Lokey since July 2015. The notice provides advance transparency about future board composition but does not indicate any disagreement with the company or its policies.

Rhea-AI Summary

Houlihan Lokey, Inc. filed a Form 8-K to furnish a press release announcing its financial results for the third fiscal quarter ended December 31, 2025. The press release is attached as Exhibit 99.1 and provides the detailed quarterly results.

The company states that the information in Item 2.02 and Exhibit 99.1 is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and is not automatically incorporated into other securities law filings.

Rhea-AI Summary

Houlihan Lokey, Inc. entered into an amended and restated voting trust agreement with designated trustees on December 30, 2025. This agreement replaces the prior 2015 voting trust arrangements for Class B common stock and updates how long the trust lasts and how it votes shares.

The revised agreement now ends on the earliest of an agreed written termination, 10 years after the date all Class B common stock automatically converts into Class A common stock, or when the trust holds less than 5% of the company’s total outstanding common stock. After that conversion date, if the trust holds more than 30% of outstanding common stock, any such excess shares must be voted in the same proportion as all other stockholders on any proposal.

The agreement also permits former employees who have not worked at the company for at least 12 months to have their shares released from the trust after the conversion date, and broadens situations where employees may withdraw shares for certain pledging, hedging, monetization or similar transactions, if allowed by the insider trading policy. Because some directors are trustees and trust participants, a Special Committee of disinterested directors reviewed and unanimously approved the new agreement.

Rhea-AI Summary

Houlihan Lokey, Inc. (HLI) furnished an 8-K to announce its financial results for the second fiscal quarter ended September 30, 2025. The company provided the details via a press release attached as Exhibit 99.1.

The information was furnished under Item 2.02 (Results of Operations and Financial Condition) and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The press release is dated October 30, 2025.

Rhea-AI Summary

Houlihan Lokey, Inc. disclosed that, effective with his start on the board, non-employee director Mr. Mund received an award of restricted Class A common stock under the company's Amended and Restated 2016 Incentive Award Plan. The award has a value equal to $100,000 and vests in substantially equal installments on the first, second and third anniversaries of the grant date, subject to his continuing service through each vesting date. The filing is dated October 6, 2025 and was signed by the company’s General Counsel and Secretary.

Rhea-AI Summary

Houlihan Lokey, Inc. reported the results of its annual stockholder meeting held on September 17, 2025. Stockholders elected three Class I directors to serve until the 2028 annual meeting, with Scott L. Beiser receiving 190,098,660 votes for, Todd J. Carter receiving 190,572,180 votes for, and Paul A. Zuber receiving 184,094,657 votes for, alongside broker non-votes in each case.

Stockholders approved, on a non-binding advisory basis, the compensation of the named executive officers, with 201,286,055 votes for, 8,431,930 against, and 32,712 abstentions, plus 2,100,021 broker non-votes. They also ratified the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending March 31, 2026, with 210,493,516 votes for, 1,332,861 against, and 24,341 abstentions.